Prophylaxis and Management of Atrial Fibrillation After General Thoracic Surgery

Thoracic Surgery Clinics

Volumn 22, Issue 1, 2012, Pages 13-23

  Merritt, Robert E ^a   Shrager, Joseph B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Anticoagulation; Atrial arrhythmia; Thoracic surgery

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ENCAINIDE; FLECAINIDE; IBUTILIDE; MAGNESIUM; METOPROLOL; MORACIZINE; NORADRENALIN; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULANT THERAPY; ATAXIA; BLOOD TRANSFUSION; BRADYCARDIA; BRONCHOSPASM; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ESOPHAGUS RESECTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTHYROIDISM; HYPOTENSION; HYPOTHYROIDISM; INSOMNIA; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER DYSFUNCTION; LOADING DRUG DOSE; LUNG COMPLICATION; LUNG EDEMA; LUNG FIBROSIS; LUNG LOBECTOMY; LUNG RESECTION; LUNG TOXICITY; LUNG TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; NORADRENALIN BLOOD LEVEL; PHLEBITIS; PHOTOSENSITIVITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SINUS RHYTHM; SURGICAL RISK; THORACOSCOPY; THORACOTOMY; THROMBOEMBOLISM; TORSADE DES POINTES; TREMOR;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DISEASE MANAGEMENT; HUMANS; MORBIDITY; PROGNOSIS; RISK FACTORS; THORACIC SURGICAL PROCEDURES;

EID: 81855185398     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2011.08.016     Document Type: Review

References (63)

1. Vaporciyan A.A., Correa A.M., Rice D.C., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 2004, 127:779-786.
2. Bloom H.L. Concise review of atrial fibrillation: treatment update considerations in light of AFFIRM and RACE. Clin Cardiol 2004, 27:495-500.
3. Fernando H.C., Jaklitsch M.T., Walsh G.L., et al. The society of thoracic surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg 2011, 92(3):1144-1152.
4. Falk R.H. Etiology and complications of atrial: insights from pathology studies. Am J Cardiol 1998, 821:10N-17N.
5. Falk R.H. Atrial fibrillation. N Engl J Med 2001, 344:1067-1078.
6. Konnings K.T., Kirchof C.J., Smeets J.R., et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994, 89:1665-1680.
7. Cooklin M., Gold M.R. Implications and treatment of atrial fibrillation after cardiothoracic surgery. Curr Opin Cardiol 1998, 13:20-27.
8. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659-666.
9. Asamura H., Naruke T., Tsuchiya R., et al. What are the risk factors for arrhythmias after thoracic operations? A retrospective multivariate analysis of 267 consecutive thoracic operations. J Thorac Cardiovasc Surg 1993, 106:1104-1110.
10. Rena O., Papalia E., Oliaro A., et al. Supraventricular arrhythmias after resection surgery of the lung. Eur J Cardiothorac Surg 2001, 20:688-693.
11. Murthy S.C., Law S., Whooley B.P., et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003, 126:1162-1167.
12. Nielsen T.D., Bahnson T., Davis R.D., et al. Atrial fibrillation after pulmonary transplant. Chest 2004, 126:496-500.
13. Harpole D.H., Liptay M.J., DeCamp M.M., et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrythmias. Ann Thorac Surg 1996, 61:977-982.
14. McKenna R.J., Houck W., Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006, 81(2):421-425.
15. Paul S., Altorki N.K., Sheng S., et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010, 139:366-378.
16. Onaitis M.W., Petersen R.P., Balderson S.S., et al. Thoracoscopic lobectomy is safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006, 244:420-425.
17. Nattel S., Rango R.E., Van Loon G. Mechanism of propranolol withdrawal phenomena. Circulation 1979, 59:1158-1164.
18. Salazar C., Frishman W., Friedman S., et al. Beta-Blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology 1979, 30:816-819.
19. Abel R.M., Van Gelder H.M., Pores I.H., et al. Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Arch Surg 1983, 118:727-731.
20. Kalman J.M., Munawar M., Howes L.G., et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995, 60:1709-1715.
21. Sedrakyan A., Treasure T., Browne J., et al. Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials. J Thorac Cardiovasc Surg 2005, 129:997-1005.
22. Amar D., Roistracher N., Rusch V.W., et al. Effects of Diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg 2000, 120:790-798.
23. Lindgren L., Lepantalo M., von Knorring J., et al. Effect of Verapamil on right ventricular pressure and atrial tachyarrhythmia after thoracotomy. Br J Anaesth 1991, 66:205-211.
24. Van Mieghem W., Coolen L., Malysse I., et al. Amiodarone and the development of ARDS after lung surgery. Chest 1994, 105:1642-1645.
25. Van Mieghem W., Tits G., Demuynck T., et al. Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann Thorac Surg 1996, 61:1083-1085.
26. Amar D., Roisttracher N., Burt M.E., et al. Effects of Diltiazem versus digoxin in dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg 1997, 63:1374-1381.
27. Shimada M., Namai H., Morisaki H., et al. Preventative use of diltiazem to suppress supraventricular tachyarrhythmia in the patients after esophagectomy. Masui 1997, 46:658-663.
28. Tisdale J.E., Wroblewski H.A., Wall D.S., et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg 2009, 88:886-893.
29. Tisdale J.E., Wroblewski H.A., Wall D.S., et al. A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2010, 140:45-51.
30. Jacobsen C.J., Bille S., Ahlburg P., et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 1997, 11:746-751.
31. Bayliff C.D., Massel D.R., Inculet R.I., et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999, 67:182-186.
32. Casthely P.A., Yoganathan T., Komer C., et al. Magnesium and arrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1994, 8:188-191.
33. Shiga T., Wajima Z., Inoue T., et al. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med 2004, 117:325-333.
34. Terzi A., Furlan G., Chiavacci P., et al. Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate. Thorac Cardiovasc Surg 1996, 44:300-303.
35. Amar D. Postoperative atrial fibrillation. Heart Dis 2002, 4:117-123.
36. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347:1825-1833.
37. VanderLugt J.T., Mattioni T., Denker S., et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 1999, 100:329-375.
38. Hilleman D.E., Spinler S.A. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacotherapy 2002, 222:66-74.
39. Khan I.A., Metha N.J., Gowda R.M. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 2003, 89:239-248.
40. Tisdale J.E., Padhi I.D., Goldberg A.D., et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998, 135:739-747.
41. Olshansky B., Rosen feld L.E., Warner A.L., et al. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004, 43:1201-1208.
42. Basler J.R., Martinez E.A., Winters B.D., et al. Beta-adrenergic blockage accelerates conversion to postoperative supraventricular tachyarrhythmias. Anesthesiology 1998, 89:1052-1059.
43. Lewis R.V., McMurray J., McDevitt D.G. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol 1989, 131:1-6.
44. Farshi R., Kistner D., Sarma J.S., et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study for five drug regimens. J Am Coll Cardiol 1999, 33:304-310.
45. Channner K.S., James M.A., MacConnell T., et al. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity. Br J Clin Pharmacol 1994, 37:53-57.
46. Ormiston T.M., Salpeter S.R. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice. Heart Fail Monit 2003, 4:45-54.
47. Khosla S., Kunjummen B., Khaleel R., et al. Safety of therapeutic beta-blockade in patients with coexisting bronchospastic airway disease and coronary artery disease. Am J Ther 2003, 10:48-50.
48. McNamara R.L., Tamariz I.J., Segal J.B., et al. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electical cardioversion, and echocardiography. Ann Intern Med 2003, 139:1018-1033.
49. McAlister H.F., Luke R.A., Whitlock R.M., et al. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. J Thorac Cardiovasc Surg 1990, 99:911-918.
50. Reisinger J., Gatterer E., Lang W., et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 2004, 25:1318-1324.
51. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 2006, 8:651-745.
52. Barbetakis N., Vassiliadis M. Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?. BMC Surg 2004, 4:7.
53. Bernard E.O., Schmid E.R., Scmidlin D., et al. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Crit Care Med 2003, 31:1031-1034.
54. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrythmia Suppression Trial. N Engl J Med 1991, 324:781-788.
55. Atiral Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449-1457.
56. Hart R.G., Pearce L.A., McBride R., et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999, 30:1223-1229.
57. Petersen P., Boysen G., Godtfredson J., et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications on chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989, 1:175-179.
58. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 1990, 323:1505-1511.
59. Stroke Prevention in Atrial Fibrillation Investigtors Stroke Prevention in Atrial Fibrillation study. Final results. Circulation 1991, 84:527-539.
60. Ezekowitz M.D., Bridges S.L., James K.E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992, 327:1406-1412.
61. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. Arch Intern Med 1997, 157(11):1237-1240.
62. Hart R.G., Benavente O., McBride R., et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999, 131:492-501.
63. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: anti-thrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857-867.